“Human myeloma RPMI8226 cells and normal cells have different sensitivity to bisilicate silver nanoparticles in vitro”, Вопр. онкол., vol. 67, no. 5, pp. 724–730, Oct. 2021, doi: 10.37469/0507-3758-2021-67-5-724-730.